| | | | | | | | | | |
|
| |
|
| Dockets Entered
On July 3, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 2000D-1306
|
| Content & Format of the Adverse Reactions Section of Labeling
|
|
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
|
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
|
|
| 2005N-0290
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Importers Entry Notice
|
|
|
|
|
| 2006D-0191
|
| Guidance for Industry and Food and Drug Administration; Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
|
|
|
|
|
| 2006N-0109
|
| General and Plastic Surgery Devices; Reclassification of the Topical Oxygen Chamber for Extremities
|
|
|
|
|
| 2006P-0124
|
| Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
|
|
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
|
|
| 2006P-0251
|
| Label change or removal from the market of the psychotropic drug Depakote
|
|
|
|
|
| 2006P-0272
|
| ANDA Suitability for 0.9% Sodium Chloride Injection
|
|
|
|
|
| 2006P-0273
|
| ANDA for Water for Injection, USP, in 3-, 5-, 15-, and 30-mL volumes
|
|
|
|
|
| 2006V-0244
|
| Laser Light Show
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET 17970
|
| Sunrider International
|
| Vol #:
|
| 165
|
|
|
|
|
| LET 17971
|
| Sunrider International
|
| Vol #:
|
| 165
|
|
|
|
|
| LET 17972
|
| Sunrider International
|
| Vol #:
|
| 165
|
|
|
|
|
| 2000D-1306
|
| Content & Format of the Adverse Reactions Section of Labeling
|
|
|
|
|
| EC 13
|
| Hoffmann-La Roche, Inc. (Roche)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
|
|
| EC 25
|
| Mr. Dave Lowe
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 26
|
| Mr. Dave Lowe
|
| Vol #:
|
| 5
|
|
|
|
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
|
|
| EC 64
|
| Ms. Judith Hathaway
|
| Vol #:
|
| 3
|
|
|
|
|
| 2005N-0290
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Importers Entry Notice
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
| |
|
| 2006D-0191
|
| Guidance for Industry and Food and Drug Administration; Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
|
|
|
|
|
| C 2
|
| New Jersey Medical School - UMDNJ
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0109
|
| General and Plastic Surgery Devices; Reclassification of the Topical Oxygen Chamber for Extremities
|
|
|
|
|
| EC 7
|
| Dr. ss ss
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0124
|
| Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
|
|
